skip to Main Content
Dr. Luis Diaz, pancreatic cancer researcher

An Immunotherapy Game Changer

Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.
Back To Top